Colibactin's mechanism of action involves the formation of DNA adducts, which are alterations in the DNA structure that can interfere with replication and transcription. These adducts can cause double-strand breaks and other types of DNA lesions. If the damage is not repaired correctly, it can result in mutations that contribute to the development of cancer.
